4-Desoxymescaline, or 4-methyl-3,5-dimethoxyphenethylamine, is a mescaline analogue related to other psychedelic phenethylamines. It is commonly referred to as DESOXY. DESOXY was discovered by Alexander Shulgin and published in his book PiHKAL.
Names | |
---|---|
Preferred IUPAC name
2-(3,5-Dimethoxy-4-methylphenyl)ethan-1-amine | |
Other names
3,5-Dimethoxy-4-methylphenethylamine
| |
Identifiers | |
| |
3D model (JSmol)
|
|
ChEMBL |
|
ChemSpider |
|
PubChem CID
|
|
UNII |
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C11H17NO2 | |
Molar mass | 195.26 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
verify (what is ?)
Infobox references
|
The effects of DESOXY vary significantly from mescaline, despite their chemical similarity.[citation needed]
A typical dosage is within the range of 40–120 mg and lasts 6–8 hours.[1]
In 1970 the Controlled Substances Act placed mescaline into Schedule I in the United States. It is similarly controlled in other nations. Depending on whether or not it is intended for human consumption, 4-desoxymescaline could be considered an analogue of mescaline, under the Federal Analogue Act and similar bills in other countries, making it illegal to manufacture, buy, possess, or distribute without a DEA or related license.
DESOXY is also an isomer of 2C-D which makes it a schedule 1 drug in the United States.